1993
DOI: 10.1172/jci116354
|View full text |Cite
|
Sign up to set email alerts
|

Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro.

Abstract: Recently we demonstrated that the nonadherent (to plastic) fraction of human PBMC could be activated by

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

8
79
0

Year Published

1994
1994
2014
2014

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 82 publications
(88 citation statements)
references
References 36 publications
8
79
0
Order By: Relevance
“…Nevertheless, the inability of IgG1 to confer protection in the SCID, CD4 Ϫ/Ϫ , and IFN-␥-deficient mice, and the restitution of IgG1-mediated protection when IFN-␥ was administered to the CD4 Ϫ/Ϫ mice, focuses attention on Th1 T cells and their role in activating macrophages and other effector cells. Other cytokines such as interleukins 2, 10, 12, and 13; transforming growth factor ␤; and granulocyte͞macrophage colonystimulating factor play important roles in regulating the activation of immune effector cells in cryptococcal infection (40)(41)(42). Nevertheless, IFN-␥ alone administered at the beginning of the infection was sufficient to produce antibodymediated protection in this model of infection.…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, the inability of IgG1 to confer protection in the SCID, CD4 Ϫ/Ϫ , and IFN-␥-deficient mice, and the restitution of IgG1-mediated protection when IFN-␥ was administered to the CD4 Ϫ/Ϫ mice, focuses attention on Th1 T cells and their role in activating macrophages and other effector cells. Other cytokines such as interleukins 2, 10, 12, and 13; transforming growth factor ␤; and granulocyte͞macrophage colonystimulating factor play important roles in regulating the activation of immune effector cells in cryptococcal infection (40)(41)(42). Nevertheless, IFN-␥ alone administered at the beginning of the infection was sufficient to produce antibodymediated protection in this model of infection.…”
Section: Discussionmentioning
confidence: 99%
“…The organisms were maintained on Sabouraud dextrose slants (Difco) and passaged to fresh slants every month as previously described (21). CFU were determined as previously described (22)(23)(24). C. neoformans (2 ϫ …”
Section: Semiquantitative Rt-pcrmentioning
confidence: 99%
“…A CFU assay was performed, as previously described (33)(34)(35). C. neoformans (2 ϫ 10 3 /well) were incubated with or without YT cells (E:T ϭ 200:1 to 500:1, unless otherwise specified).…”
Section: Anticryptococcal Activity Of Yt Cellsmentioning
confidence: 99%